Enrofloxacin Base IP is a fluoroquinolone antibiotic. Enrofloxacin is currently FDA-approved for treatment of individual pets and domestic animals in the United States. Fluoroquinolones such as ciprofloxacin are widely used in the treatment of human disease.
Enrofloxacin is a broad-spectrum antibiotic used in veterinary medicine to treat animals afflicted with certain bacterial infections. Enrofloxacin may be an appropriate treatment option for Pseudomonas aeruginosa, Klebsiella.
Enrofloxacin is a fluoroquinolone antibiotic used to treat bacterial infections. Its use in dogs to treat certain specific infections and its use in small mammals, birds, and reptiles is 'off label' or 'extra label'. Many drugs are commonly prescribed for off label use in veterinary medicine
Promois International - Pharmaceutical Raw Material Powder Manufacturer, Supplier And Exporter
Enrofloxacin and orbifloxacin are similar agents. Enrofloxacin is metabolized to ciprofloxacin. Enrofloxacin enters the tears in inhibitory concentrations for most common pathogens. It is eliminated by glomerular filtration and biliary secretion. Enrofloxacin has toxic properties in humans. It is for veterinary use only. Enrofloxacin should not be used in pregnant, or nursing pets or in immature dogs unless the severity of the infection warrants it.